Publications

A SYNTHETIC AGONIST TO VASOACTIVE INTESTINAL PEPTIDE RECEPTOR-2 INDUCES REGULATORY T CELL NEUROPROTECTIVE ACTIVITIES IN MODELS OF PARKINSON’S DISEASE

Mosley et al. Front. Cell. Neurosci. 2019
Click to read.

MANGANESE-ENHANCED MAGNETIC RESONANCE IMAGING FOR DETECTION OF VASOACTIVE INTESTINAL PEPTIDE RECEPTOR 2 AGONIST THERAPY IN A MODEL OF PARKINSON’S DISEASE

Olson et al. Neurotherapeutics 2016

Click to read.

SELECTIVE VIP RECEPTOR AGONISTS FACILITATE IMMUNE TRANSFORMATION FOR DOPAMINERGIC NEUROPROTECTION IN MPTP-INTOXICATED MICE

Olson et al. Journal of Neurscience 2015
Click to read.

USE OF BACKBONE MODIFICATION TO ENLARGE THE SPATIOTEMPORAL DIVERSITY OF PARATHYROID HORMONE RECEPTOR-1 SIGNALING VIA BASED AGONISM

Liu et al. J.AM Chem. Soc. 2019
Click to read.

DEVELOPMENT OF POTENT, PROTEASE-RESISTANT AGONISTS OF THE PARATHYROID HORMONE RECEPTOR WITH BROAD B RESIDUE DISTRIBUTION

Cheloha et al. J. Med .Chem. 2017
Click to read.

BACKBONE MODIFICATION OF A POLYPEPTIDE DRUG ALTERS DURATION OF ACTION IN VIVO

Cheloha et al. Nature Biotechnology 2014
Click to read.